Избранные публикации (Selected Publications)

Избранные публикации  (Selected Publications)

Tenenbaum A, Leor J, Motro M, Hod H, Kaplinsky E, Rabinoviz B,Boyko V, Vered Z. Improved posterobasal segmental function following thrombolysis is associated with decreased incidence of significant mitral regurgitation in first inferior myocardial infarction. J Am Coll Cardiol, 1995;25:1558-63.

Tenenbaum A, Motro M, Hod H, Kaplinsky E, Vered Z: Shortened Doppler-derived mitral A-wave deceleration time is an important predictor of elevated left ventricular filling pressure. J Am Coll Card, 1996;27:700-705.

Tenenbaum A., Garniek A., Shemesh J., Fisman EZ., Stroh CI., Itzchak Y., Vered Z., Motro, M.: Double helical computed tomography: a detector of aortic atheromas as a source of stroke. Comparison with transesophageal echocardiography.Radiology, 1998;208: 153-158, 1998.

Tenenbaum A., Fisman EZ., Boyko V., Goldbourt U., Graff E.,Shemesh J., Shotan A., Reicher-Reiss H., Behar S., Motro M.:Hypertension in diet-treated versus pharmacologically-treated diabetics: mortality over a 5-year follow-up. Hypertension 33:1002-1007, 1999.

Tenenbaum A., Motro M., Feinberg MS., Schwammenthal E., Stroh CI., Vered Z., Fisman EZ.:Retrograde flow in the thoracic aorta in patients with systemic emboli: A transesophageal echocardiographic evaluation of mobile plaque motion. Chest 37:125-128, 2000.

Tenenbaum A., Motro M., Fisman EZ., Boyko V., Mandelzweig L., Shotan A., Behar S.: Does participation itself in a long-term clinical trial lead to survival gain for patients with coronary artery disease? The American Jounal of Medicine 112:545-548, 2002.

Tenenbaum A, Motro M, Fisman EZ, Leor J, Freimark D, Boyko V, Mandelzweig L, Adler Y, Sherer Y, Behar S. Functional class in patients with heart failure is associated with the development of diabetes. The American Jounal of Medicine 2003;114:271-5

Tenenbaum A, Motro M, Fisman EZ, Schwammenthal E, Adler Y, Goldenberg I, Leor J, Boyko V, Mandelzweig L, Behar S: Peroxisome Proliferator-Activated Receptors Ligand Bezafibrate for Prevention of Type 2 Diabetes Mellitus in Patients with Coronary Artery Disease. Circulation, 2004;109:2197-202

Tenenbaum A, Motro M, Fisman EZ, Tanne D, Boyko V, Behar S: Fibric Acid Derivative Bezafibrate for the Secondary Prevention of Myocardial Infarction in Patients with the Metabolic Syndrome. Archives of Internal Medicine, 2005;165:1154-60.

Tenenbaum A, Motro M, Fisman EZ, Adler Y, Schwammenthal E, Shemesh J.,Tanne D, Boyko V, Behar S: Effect of Bezafibrate on Incidence of Type 2 Diabetes Mellitus in Obese Patients. European Heart Journal, 2005; 26: 2032-2038.Eisen A, Tenenbaum A, Koren-Morag N, Tanne D, Shemesh J, Imazio M, Fisman EZ, Motro M, Schwammenthal E, Adler Y. Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death. Circulation. 2008;118:1328-34.

Tenenbaum A, Fisman EZ, Motro M, Adler Y. Optimal management of combined dyslipidemia: what have we behind statins monotherapy? Adv Cardiol. 2008;45:127-53.

Copyright © 2019 CardioLines. All rights reserved.